# Clinical Pharmacology of Miami, Inc – FDA Inspection, Feb 2, 2018

Source: https://www.keypedia.com/records/fda_inspections/clinical-pharmacology-of-miami-inc/f01ee291-40d0-4a50-b558-15dc035a2f42
Source feed: FDA_Inspections

> FDA inspection 1041916 of Clinical Pharmacology of Miami, Inc, February 02, 2018. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041916
- Company Name: Clinical Pharmacology of Miami, Inc
- Inspection Date: 2018-02-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1157199 - 2021-11-16](https://www.keypedia.com/records/fda_inspections/clinical-pharmacology-of-miami-inc/154ff523-8a95-45f4-842c-2856724506b4)
- FDA Inspection 1005481 - 2017-03-22

## Related Officers

- [Company Rep](https://www.keypedia.com/people/craig-a-garmendia/6a17e361-7085-4d55-92b2-37fcaf2f55de)

Company: https://www.keypedia.com/companies/clinical-pharmacology-of-miami-inc/f97da50e-cdff-4653-b23a-45742b1e66c9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c